R
Relmada Therapeutics (RLMD)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Relmada Therapeutics (RLMD)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more
- USD3.76
- USD4.00
- USD3.66
- USD7.22
- -21.90%
- --
- 115.40k
- 111M
- 2.36
- 35.30%
Stock News
4 hours ago
Disney quarterly results are on deck. Here's what to expect
CNBC
5 hours ago
Southern Company announces upsize and pricing of $1.3 billion in aggregate principal amount of Series 2024A 4.50% Convertible Senior Notes due June 15, 2027
Yahoo
5 hours ago
Elon Musk talks Mars, AI, and threats to civilization — but not a word of Tesla
Yahoo
6 hours ago
Dow Jones Futures Fall: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
